However, in squamous cell carcinoma, breast cancer, osteosarcoma, and glioma, KLF4 was shown to promote cell growth and cellular dedifferentiation, and inhibit cell apoptosis [47–49]. Here, KLF4 is linked to central nervous system cancer.